Serum cotinine level and incident hearing loss: a case-control study

Arch Otolaryngol Head Neck Surg. 2004 Nov;130(11):1260-4. doi: 10.1001/archotol.130.11.1260.

Abstract

Background: A growing body of literature suggests an association between cigarette smoking and hearing loss.

Objective: To assess the relation between levels of serum cotinine, a biomarker of exposure to tobacco smoke, and incident hearing loss.

Design: A cross-sectional, incident, case-control study of participants selected from a population-based cohort.

Setting: Testing was conducted at the Beaver Dam Community Hospital, Beaver Dam, Wis.

Participants: A total of 197 participants with incident hearing loss and 394 control participants, aged 53 to 75 years, selected from the 2800 participants of the 5-year follow-up examination of the population-based Epidemiology of Hearing Loss Study, 1998-2000.

Main outcome measure: Incident hearing loss. The incidence of hearing loss was defined as a pure-tone average of thresholds at 500, 1000, 2000, and 4000 Hz greater than 25-dB hearing level in either ear at follow-up among those without hearing loss at baseline.

Results: No significant associations were found between serum cotinine levels and incident hearing loss.

Conclusions: These results were not consistent with a previous report, which found cross-sectional associations between prevalent hearing loss and current smoking and environmental tobacco smoke exposure in the home. Longer-term longitudinal studies of smoking and/or serum cotinine levels and the subsequent development of hearing loss may help clarify these associations.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Auditory Threshold
  • Case-Control Studies
  • Confounding Factors, Epidemiologic
  • Cotinine / blood*
  • Cross-Sectional Studies
  • Effect Modifier, Epidemiologic
  • Female
  • Hearing Loss / epidemiology*
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Risk Factors
  • Smoking / epidemiology*

Substances

  • Cotinine